Literature DB >> 28005261

Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.

J Capellades1, P Teixidor2, G Villalba3, C Hostalot2, G Plans4, R Armengol2, S Medrano1, A Estival5, R Luque6, S Gonzalez1, M Gil-Gil7, S Villa8, J Sepulveda9, J J García-Mosquera5, C Balana10.   

Abstract

PURPOSE: We assessed agreement among neurosurgeons on surgical approaches to individual glioblastoma patients and between their approach and those recommended by the topographical staging system described by Shinoda.
METHODS: Five neurosurgeons were provided with pre-surgical MRIs of 76 patients. They selected the surgical approach [biopsy, partial resection, or gross total resection (GTR)] that they would recommend for each patient. They were blinded to each other's response and they were told that patients were younger than 50 years old and without symptoms. Three neuroradiologists classified each case according to the Shinoda staging system.
RESULTS: Biopsy was recommended in 35.5-82.9%, partial resection in 6.6-32.9%, and GTR in 3.9-31.6% of cases. Agreement among their responses was fair (global kappa = 0.28). Nineteen patients were classified as stage I, 14 as stage II, and 43 as stage III. Agreement between the neurosurgeons and the recommendations of the staging system was poor for stage I (kappa = 0.14) and stage II (kappa = 0.02) and fair for stage III patients (kappa = 0.29). An individual analysis revealed that in contrast to the Shinoda system, neurosurgeons took into account T2/FLAIR sequences and gave greater weight to the involvement of eloquent areas.
CONCLUSIONS: The surgical approach to glioblastoma is highly variable. A staging system could be used to examine the impact of extent of resection, monitor post-operative complications, and stratify patients in clinical trials. Our findings suggest that the Shinoda staging system could be improved by including T2/FLAIR sequences and a more adequate weighting of eloquent areas.

Entities:  

Keywords:  Glioblastoma; Intention; Inter-observer variability; Radicality; Staging; Surgery

Mesh:

Year:  2016        PMID: 28005261     DOI: 10.1007/s12094-016-1598-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  30 in total

1.  Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

Authors:  Daniela Kuhnt; Andreas Becker; Oliver Ganslandt; Miriam Bauer; Michael Buchfelder; Christopher Nimsky
Journal:  Neuro Oncol       Date:  2011-09-12       Impact factor: 12.300

Review 2.  Neurosurgical approach.

Authors:  Jennifer A Moliterno; Toral R Patel; Joseph M Piepmeier
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

3.  The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

Authors:  G E Keles; B Anderson; M S Berger
Journal:  Surg Neurol       Date:  1999-10

4.  An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

Authors:  Mark E Oppenlander; Andrew B Wolf; Laura A Snyder; Robert Bina; Jeffrey R Wilson; Stephen W Coons; Lynn S Ashby; David Brachman; Peter Nakaji; Randall W Porter; Kris A Smith; Robert F Spetzler; Nader Sanai
Journal:  J Neurosurg       Date:  2014-01-31       Impact factor: 5.115

5.  Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.

Authors:  J Shinoda; N Sakai; S Murase; H Yano; T Matsuhisa; T Funakoshi
Journal:  J Neurooncol       Date:  2001-04       Impact factor: 4.130

6.  Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis.

Authors:  Philip C De Witt Hamer; Santiago Gil Robles; Aeilko H Zwinderman; Hugues Duffau; Mitchel S Berger
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

7.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

8.  A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.

Authors:  Kaisorn Chaichana; Scott Parker; Alessandro Olivi; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2010-05       Impact factor: 5.115

9.  Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme.

Authors:  Matthew J McGirt; Debraj Mukherjee; Kaisorn L Chaichana; Khoi D Than; Jon D Weingart; Alfredo Quinones-Hinojosa
Journal:  Neurosurgery       Date:  2009-09       Impact factor: 4.654

10.  Pseudoprogression in glioblastoma patients: the impact of extent of resection.

Authors:  Hun Ho Park; Tae Hoon Roh; Seok Gu Kang; Eui Hyun Kim; Chang-Ki Hong; Se Hoon Kim; Sung Soo Ahn; Seung Koo Lee; Hye Jin Choi; Jaeho Cho; Sun Ho Kim; Kyu-Sung Lee; Chang-Ok Suh; Jong Hee Chang
Journal:  J Neurooncol       Date:  2015-11-25       Impact factor: 4.130

View more
  2 in total

1.  Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.

Authors:  Jaume Capellades; Josep Puig; Sira Domenech; Teresa Pujol; Laura Oleaga; Angels Camins; Carles Majós; Rocio Diaz; Christian de Quintana; Pilar Teixidor; Gerard Conesa; Gerard Plans; Josep Gonzalez; Natalia García-Balañà; Jose Maria Velarde; Carmen Balaña
Journal:  J Neurooncol       Date:  2017-12-28       Impact factor: 4.130

2.  Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort.

Authors:  Even Hovig Fyllingen; Lars Eirik Bø; Ingerid Reinertsen; Asgeir Store Jakola; Lisa Millgård Sagberg; Erik Magnus Berntsen; Øyvind Salvesen; Ole Solheim
Journal:  Acta Neurochir (Wien)       Date:  2021-03-20       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.